ICH targets cell and gene therapies, real-world data as topics ripe for harmonization
Regulatory NewsJoanne S. Eglovitch
Advanced therapies/cell and gene therapyBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsPharmacovigilanceQuality Assurance and ControlRegulatory Intelligence/Policy